agilon health (NYSE:AGL) Given New $2.00 Price Target at Stifel Nicolaus

agilon health (NYSE:AGL) had its price objective decreased by analysts at Stifel Nicolaus from $7.00 to $2.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the stock. Stifel Nicolaus’ target price indicates a potential upside of 6.10% from the stock’s previous close.

Other research analysts have also recently issued research reports about the company. Barclays lowered their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday. Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a research note on Wednesday, October 2nd. Evercore ISI lowered their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Benchmark reiterated a “buy” rating and set a $9.00 target price on shares of agilon health in a research report on Thursday, August 8th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $6.38.

agilon health Price Performance

Shares of AGL opened at $1.89 on Tuesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The business’s 50 day simple moving average is $3.18 and its 200-day simple moving average is $4.93. agilon health has a one year low of $1.80 and a one year high of $13.76.

agilon health (NYSE:AGL) last posted its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. As a group, equities analysts anticipate that agilon health will post -0.35 EPS for the current fiscal year.

Insiders Place Their Bets

In other agilon health news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction dated Thursday, September 12th. The stock was bought at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. The trade was a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

Institutional investors have recently added to or reduced their stakes in the stock. Arizona State Retirement System boosted its stake in agilon health by 2.5% in the second quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock valued at $562,000 after acquiring an additional 2,070 shares during the last quarter. Swiss National Bank raised its holdings in shares of agilon health by 0.6% in the 1st quarter. Swiss National Bank now owns 602,800 shares of the company’s stock worth $3,677,000 after purchasing an additional 3,400 shares during the period. J.Safra Asset Management Corp lifted its stake in agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the last quarter. CWM LLC grew its holdings in agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares during the period. Finally, Signaturefd LLC increased its position in agilon health by 166.2% in the second quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock worth $77,000 after buying an additional 7,398 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.